Rankings
▼
Calendar
SNDX FY 2022 Earnings — Syndax Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
SNDX
Syndax Pharmaceuticals, Inc.
$2B
FY 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
-100.0% YoY
Gross Profit
$0
Operating Income
-$152M
Net Income
-$149M
EPS (Diluted)
$-2.46
Cash Flow
Operating Cash Flow
-$134M
Free Cash Flow
-$134M
Stock-Based Comp.
$16M
Balance Sheet
Total Assets
$497M
Total Liabilities
$30M
Stockholders' Equity
$467M
Cash & Equivalents
$74M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$140M
-100.0%
Gross Profit
$0
$140M
-100.0%
Operating Income
-$152M
$26M
-678.8%
Net Income
-$149M
$25M
-699.1%
← Q4 2021
All Quarters
Q1 2022 →